Program Information

Wednesday, April 8     Pharmacology Preconference 
                                   

11:00 a.m. - 12:15 p.m.   Lunch
Product Theater (non-CE)

     
12:30 p.m. - 12:45 p.m.   Welcome
Course DirectorJoanna Sikkema, DNP, MSN, ANP-BC, FAHA, FPCNA
     
12:45 p.m. - 2:15 p.m.  

Antihyperglycemic Agents in the Treatment of Patients with Type 2 Diabetes 
Cindy Lamendola, MSN, ANP-BC, FAHA, FPCNA

     
 2:30 p.m. - 3:45 p.m.  

CVD Risk Reduction with Lipid-Lowering Medications: Statins and Beyond
Lynne Braun, PhD, CNP, CLS, FAHA, FPCNA, FAAN

     
3:45 p.m. - 5:00 p.m.   Pharmacotherapy for the Management of Heart Failure
Joanna Sikkema, DNP, MSN, ANP-BC, FAHA, FPCNA
     



     
5:00 p.m. - 5:30 p.m.   Case Studies with All Faculty Panel

*Pharmacology Preconference may be attended as a stand-alone event

Thursday, April 9          Annual Symposium

8:30 a.m. - 8:45 a.m.  

Welcome

     
8:45 a.m. - 9:45 a.m.  

Breakfast CE Program

     
9:45 a.m. - 10:15 a.m.  

Awards, Annual Review, President's Address

     
10:25 a.m. - 11:20 a.m.  

Exercise Really IS Medicine
Robert Sallis, MD

     
11:20 a.m. - 12:10 p.m.  

Heart Health and Brain Health: Same Formula?
Neelum Aggarwal, MD

     
12:10 p.m. - 2:10 p.m.  

Exhibits, Lunch

     
2:10 p.m. - 3:00 p.m.  

Race and Ethnicity: Impact on Heart Disease
Clyde Yancy, MD

     
Breakout Sessions   Choose Two Sessions

3:05 p.m. - 4:00 p.m.

  Beyond Scare Tactics: Effective Risk Communication Strategies
Lola A. Coke, PhD, ACNS-BC, RN-BC, FAHA, FPCNA
4:05 p.m. - 5:00 p.m.    
    Exercise is Heart Failure Medicine Too
Nancy Houston Miller, RN, BSN, FAHA, FPCNA
     
   

Management of Pregnancy in Women with Heart Disease
Mary Cannobbio, MN, RN, FAAN

     
   

Moderated Poster Sessions

     
5:00 p.m. - 6:30 p.m.   Exhibits, Opening Reception, and Poster Presentations
     

 

Friday, April 10

8:30 a.m. - 8:45 a.m.  

Opening: Fellow Recognition, Poster Winners Announced

     
8:45 a.m. - 9:45 a.m.   Breakfast CE Program

     
9:45 a.m. - 10:45 a.m.  

Exhibits

     
10:50 a.m. - 11:20 a.m.  

Winning Abstract Presentations 

     
11:20 a.m. - 12:15 p.m.  

What's a Clinician to do? Implementation of the 2013 Prevention Guidelines
Donald Lloyd Jones, MD, ScM, FACC, FAHA

     
12:15 p.m. - 2:15 p.m.   Exhibits, Lunch

     
2:15 p.m. - 3:05 p.m.  

Beyond Statins: What Does the Future of Dyslipidemia Treatment Hold?
Karol Watson, MD, PhD

     
Breakout Sessions   Choose Two Sessions

3:15 p.m. - 4:10 p.m.

  What Can We Offer the Patient with Resistant Hypertension in 2015?
Joel Handler, MD  
4:15 p.m. - 5:10 p.m.    
   

Safe Transition from H2H
Kim Newlin, RN, CNS, NP-C, FPCNA

     
   

Surgical Approaches to Obesity: Long Term Impact on CV Risk
John Morton, MD, MPH, FACS, FASMBS

     
    Cardiac Device Update: New Tools and New Indications
Robin Trupp, PhD, ACNP-BC, CHFN, FAHA
     

 

Saturday, April 11

8:15 a.m. - 8:25 a.m.  

Opening

     
8:25 a.m. - 9:25 a.m.   Breakfast CE Program

     
9:25 a.m. - 10:10 a.m.  

Women and Stroke: Guidelines for Prevention
Wende Fedder, RN, MBA, FAHA

     
10:15 a.m. - 11:00 a.m.  

Menopausal Hormone Therapy and SERMS: Cardiovascular Risks and Benefits
Cynthia Stuenkel, MD, NCMP

     
11:00 a.m. - 11:45 a.m.  

Understanding Sex Differences in Pathophysiology = Improved Treatment of Women with CVD
Marcia Stefanick 

     
11:45 a.m. - 12:30 p.m.  

Pregnancy Complications are Predictors of Cardiovascular Disease in Women
Ellen Seely, MD

     
12:35 p.m.  

Closing

Designed to blend the latest advancements in science with practical clinical approaches to patient management, PCNA’s Annual Symposium features keynote addresses, lectures and workshops presented by world-renowned authorities in cardiovascular risk reduction and disease management. New this year: Pharmacology Preconference made specifically for Advance Practice Nurses in cardiology. Pre-course work and post-course evaluation required; earn 7 hours of pharmacology credit.

2015 Schedule

Accreditation Statement

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program is accredited for 16 contact hours of continuing education, which includes 3 hours of pharmacology. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.

Access Slides from 2013 Sessions

Access slides from the 2013 PCNA 19th Annual Symposium